- Home
- SVM vs AVBP Comparison
SVM vs AVBP Comparison
Compare SVM & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- AVBP
- Stock Information
- Founded
- SVM N/A
- AVBP 2021
- Country
- SVM Canada
- AVBP United States
- Employees
- SVM N/A
- AVBP N/A
- Industry
- SVM Precious Metals
- AVBP
- Sector
- SVM Basic Materials
- AVBP
- Exchange
- SVM Nasdaq
- AVBP NYSE
- Market Cap
- SVM 663.6M
- AVBP 948.5M
- IPO Year
- SVM N/A
- AVBP 2024
- Fundamental
- Price
- SVM $3.15
- AVBP $27.10
- Analyst Decision
- SVM Strong Buy
- AVBP Strong Buy
- Analyst Count
- SVM 1
- AVBP 5
- Target Price
- SVM $5.10
- AVBP $36.80
- AVG Volume (30 Days)
- SVM 2.9M
- AVBP 148.6K
- Earning Date
- SVM 02-06-2025
- AVBP 02-02-2025
- Dividend Yield
- SVM 0.81%
- AVBP N/A
- EPS Growth
- SVM 63.39
- AVBP N/A
- EPS
- SVM 0.29
- AVBP N/A
- Revenue
- SVM $241,357,000.00
- AVBP N/A
- Revenue This Year
- SVM $32.50
- AVBP N/A
- Revenue Next Year
- SVM $6.46
- AVBP N/A
- P/E Ratio
- SVM $10.65
- AVBP N/A
- Revenue Growth
- SVM 16.71
- AVBP N/A
- 52 Week Low
- SVM $2.22
- AVBP $14.35
- 52 Week High
- SVM $5.32
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- SVM 46.17
- AVBP 47.58
- Support Level
- SVM $2.88
- AVBP $26.36
- Resistance Level
- SVM $3.09
- AVBP $27.67
- Average True Range (ATR)
- SVM 0.11
- AVBP 1.20
- MACD
- SVM 0.05
- AVBP 0.13
- Stochastic Oscillator
- SVM 72.37
- AVBP 78.34
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.